Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1974 1
1976 2
1977 3
1978 3
1979 2
1980 2
1981 1
1982 4
1983 6
1984 3
1985 5
1986 2
1987 4
1988 2
1989 7
1990 2
1991 1
1992 2
1993 3
1994 1
1996 5
1997 2
1998 3
1999 2
2001 2
2019 2
2021 4
2022 4
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Ribosome-tetracycline interactions.
Tritton TR. Tritton TR. Biochemistry. 1977 Sep 6;16(18):4133-8. doi: 10.1021/bi00637a029. Biochemistry. 1977. PMID: 334241 No abstract available.
Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJF, Quint JK, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2023 Sep 15;18:2039-2054. doi: 10.2147/COPD.S408688. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37731774 Free PMC article.
Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo CM, Yeap J, Wild R, Compton C, Rothnie KJ, Herth F, Quint JK, Ismaila AS. Requena G, et al. Among authors: tritton t. Int J Chron Obstruct Pulmon Dis. 2023 Jul 13;18:1431-1444. doi: 10.2147/COPD.S411437. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37465818 Free PMC article.
Cell surface actions of adriamycin.
Tritton TR. Tritton TR. Pharmacol Ther. 1991;49(3):293-309. doi: 10.1016/0163-7258(91)90060-y. Pharmacol Ther. 1991. PMID: 2052627 Review.
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study.
Czira A, Banks V, Requena G, Wood R, Tritton T, Wild R, Compton C, Ismaila A. Czira A, et al. Among authors: tritton t. BMJ Open. 2024 Feb 7;14(2):e072361. doi: 10.1136/bmjopen-2023-072361. BMJ Open. 2024. PMID: 38326272 Free PMC article.
Spin-labeled ribosomes.
Tritton TR. Tritton TR. Biochemistry. 1978 Sep 19;17(19):3959-64. doi: 10.1021/bi00612a013. Biochemistry. 1978. PMID: 213100 No abstract available.
Anthracycline resistance.
Bhushan A, Kermode JC, Posada J, Tritton TR. Bhushan A, et al. Among authors: tritton tr. Cancer Treat Res. 1989;48:55-72. doi: 10.1007/978-1-4613-1601-5_5. Cancer Treat Res. 1989. PMID: 2577141 Review. No abstract available.
93 results